FierceBiotech ٢٣ مارس ٢٠٢٦ Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech ٢٠ مارس ٢٠٢٦ Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial
FierceBiotech ٢٠ مارس ٢٠٢٦ Gilead turns down chance to build on Assembly's phase 1-stage HBV antiviral
FierceBiotech ٢٠ مارس ٢٠٢٦ Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
FierceBiotech ٢٠ مارس ٢٠٢٦ Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin
FierceBiotech ١٩ مارس ٢٠٢٦ Lilly's obesity discovery partner Fauna sees weight loss potential in hibernating mammals
FierceBiotech ١٩ مارس ٢٠٢٦ AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
FierceBiotech ١٩ مارس ٢٠٢٦ Phage-focused BiomX resets after adverse events derail pipeline, considers pivot to defense sector
FierceBiotech ١٩ مارس ٢٠٢٦ Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’
FierceBiotech ١٩ مارس ٢٠٢٦ Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech ١٩ مارس ٢٠٢٦ Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress